Freezing of gait, or FOG, is said to affect approximately 7% of individuals with early Parkinson’s disease (PD) and more than half of those with advanced PD.1This is due to the loss of postural reflexes, which are automatic movements that help us maintain equilibrium and balance when we are standing upright. FOG is usually defined as an onset of not being able to start stepping forward, with no apparent cause, and can be exacerbated by stress or distraction.1 FOG can look like trembling of the legs, shortening of steps or shuffling, or feeling like one is unable to move their feet.2 It’s one of the most debilitating aspects of PD and can increase fall risk. While there is no known cure for this, there are potential treatments for it, and ways to prevent FOG are being explored.
This report contains market size and forecasts of Freezing of Gait Treatment in Global, including the following market information:
Global Freezing of Gait Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Freezing of Gait Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Dopaminergic Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Freezing of Gait Treatment include Acorda Therapeutics, The Michael J. Fox Foundation, GYENNO, MedEXO Robotics and TABLE Teva Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Freezing of Gait Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Freezing of Gait Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Freezing of Gait Treatment Market Segment Percentages, by Type, 2021 (%)
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Global Freezing of Gait Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Freezing of Gait Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research and Academic Institutes
Global Freezing of Gait Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Freezing of Gait Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Freezing of Gait Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Freezing of Gait Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals